Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Prostate cancer cells gain unnatural ability to change shape and spread

Johns Hopkins Kimmel Cancer Center scientists report they have discovered a biochemical process that gives prostate cancer cells the almost unnatural ability to change their shape, squeeze into other organs and take root in other parts of the body.

8 Aug 2017

Neuroscientists uncover genetic basis for formation of meningiomas in childhood cancer survivors

Neuroscientists have uncovered the genetic basis for why many long-term survivors of childhood cancer develop meningiomas, the most common adult brain tumor, decades after their treatment with cranial radiation.

4 Aug 2017

PerkinElmer introduces affordable clinical genomics services

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced the launch of PerkinElmer Genetics' clinical genomics services.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

Researchers reveal potential of radiomics to improve precision medicine

Precision medicine has become the leading innovation of cancer treatment. Patients are routinely treated with drugs that are designed to target specific tumors and molecules.

3 Aug 2017

UCLA research in sarcoma provides much-needed roadmap for personalizing therapies

Sarcoma is a rare and deadly form of cancer occurring in the bones and connective tissue that affects individuals of all ages.

3 Aug 2017

Breast cancer patients treated with targeted radiotherapy experience fewer side effects

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet today (Wednesday).

3 Aug 2017

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2017 Annual Meeting in Denver, Colorado. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions.

2 Aug 2017

ASTRO selects 23 exemplary members to receive Fellows designation

The American Society for Radiation Oncology has selected 23 distinguished members to receive the ASTRO Fellow designation. The 2017 class of Fellows will be recognized during the Awards Ceremony at ASTRO's 59th Annual Meeting, to be held September 24-27 in San Diego.

2 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Researchers ferreting out patients most likely to become resistant to cancer treatment

According to the National Cancer Institute, the number of people beating a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Now, that's good news, but it doesn't mean that cancer researchers - in the lab or clinic - are resting on any laurels.

2 Aug 2017

Scientists reveal new method to reprogram specific T cells

When the immune system is imbalanced, either due to overly-active cells or cells that suppress its function, it causes a wide range of diseases, from psoriasis to cancer.

2 Aug 2017

Takeda and Cardurion announce creation of new cardiovascular development partnership

Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals today announced the creation of a new cardiovascular development partnership.

2 Aug 2017

Hospitalized cancer patients who suffer cardiac arrest have lower survival rate, study finds

Patients with advanced cancer who suffer cardiac arrest in the hospital have a survival rate of less than 10 percent--half the rate of other patients without cancer, according to a nationwide study led by the University of Rochester Medical Center.

2 Aug 2017

MR Solutions’ dry magnet system provides high resolution imaging within compact footprint

When it comes to choosing a preclinical MRI imaging system there is no need to compromise – MR Solutions’ 9.4T cryogen free, or dry magnet system provides state of the art high resolution imaging within a compact footprint.

2 Aug 2017

Shaping the future of oncology treatment

Victories Over Cancer is about enabling those affected by cancer to enjoy more of life’s meaning full moments and making cancer more manageable. At Janssen, we're really thinking about the elimination of cancer, and we take a very deliberate approach to that.

2 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

Oncology News and Research

Further Reading

Prostate cancer cells gain unnatural ability to change shape and spread

Neuroscientists uncover genetic basis for formation of meningiomas in childhood cancer survivors

PerkinElmer introduces affordable clinical genomics services

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

Researchers reveal potential of radiomics to improve precision medicine

UCLA research in sarcoma provides much-needed roadmap for personalizing therapies

Breast cancer patients treated with targeted radiotherapy experience fewer side effects

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

ASTRO selects 23 exemplary members to receive Fellows designation

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Researchers ferreting out patients most likely to become resistant to cancer treatment

Scientists reveal new method to reprogram specific T cells

Takeda and Cardurion announce creation of new cardiovascular development partnership

Hospitalized cancer patients who suffer cardiac arrest have lower survival rate, study finds

MR Solutions’ dry magnet system provides high resolution imaging within compact footprint

Shaping the future of oncology treatment

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

Natural compounds in thyme and oregano may offer treatment for cachexia

Study shows link between history of gum disease and increased cancer risk in older women

New law in Rhode Island mandates fertility preservation coverage prior to medical treatment

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News